These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2266390)

  • 21. Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.
    Coleman RE; Stubbs JB; Barrett JA; de la Guardia M; Lafrance N; Babich JW
    Cancer Biother Radiopharm; 2009 Aug; 24(4):469-75. PubMed ID: 19694582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
    Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
    Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intracellular uptake and accumulation of metaiodobenzylguanidine in neuroblastoma cells and small cell carcinoma of the lung].
    Melino G
    Minerva Pediatr; 1989 Mar; 41(3):123-8. PubMed ID: 2546031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefit.
    Tristam M; Alaamer AS; Fleming JS; Lewington VJ; Zivanovic MA
    J Nucl Med; 1996 Jun; 37(6):1058-63. PubMed ID: 8683301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.
    Koral KF; Wang XH; Sisson JC; Botti J; Meyer L; Mallette S; Glazer GM; Adler RS
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):211-8. PubMed ID: 2787315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.
    Nakajo M; Shapiro B; Glowniak J; Sisson JC; Beierwaltes WH
    J Nucl Med; 1983 Dec; 24(12):1127-34. PubMed ID: 6644373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of malignant pheochromocytoma treated by 131I-metaiodobenzylguanidine.
    Theilade K; Bak M; Olsen K; Nielsen SL; Christensen NJ
    Acta Oncol; 1988; 27(3):296-7. PubMed ID: 3415861
    [No Abstract]   [Full Text] [Related]  

  • 28. Uptake of 131I-metaiodobenzylguanidine by 6-23 rat medullary thyroid carcinoma.
    Poston GJ; Fawcett HD; Townsend CM; James E; Lieg JL; Nusynowitz ML; Thompson JC
    Life Sci; 1989; 44(21):1611-6. PubMed ID: 2786600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma].
    Aritake S; Kusakabe K; Kanaya S; Kanaya K; Nakano K; Ota T; Maki M; Shigeta A
    Kaku Igaku; 1993 Jan; 30(1):51-60. PubMed ID: 8455341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
    Bestagno M
    J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
    Hoefnagel CA; den Hartog Jager FC; Taal BG; Abeling NG; Engelsman EE
    Eur J Nucl Med; 1987; 13(4):187-91. PubMed ID: 2441993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
    J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric considerations in 131I-MIBG therapy for neuroblastoma in children.
    Bolster AA; Hilditch TE; Wheldon TE; Gaze MN; Barrett A
    Br J Radiol; 1995 May; 68(809):481-90. PubMed ID: 7788233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radionuclide therapy of neural crest tumors.
    Voûte PA; Hoefnagel CA; de Kraker J; Evans AE; Hayes A; Green A
    Med Pediatr Oncol; 1987; 15(4):192-5. PubMed ID: 3657706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The radiation dose to the urinary bladder in radio-iodine therapy.
    Bolster AA; Hilditch TE
    Phys Med Biol; 1996 Oct; 41(10):1993-2008. PubMed ID: 8912376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.
    Hoefnagel CA; Den Hartog Jager FC; Van Gennip AH; Marcuse HR; Taal BG
    Clin Nucl Med; 1986 Mar; 11(3):150-2. PubMed ID: 3956021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of distant metastases of a phaeochromocytoma with 131I-metaiodobenzylguanidine. A case report.
    Esser J; Aronovitz F; Savitch I; Browde S; Rabin S; Levin J; Van Wyk AJ
    S Afr Med J; 1984 Jun; 65(26):1057-8. PubMed ID: 6740421
    [No Abstract]   [Full Text] [Related]  

  • 38. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic possibilities of 131I-MIBG in metastatic carcinoid tumors--preliminary report.
    Guerra P; Colombo L; Maira G; Pagliaini R; Terzi A; Pizzocaro C; Dottorini ME; Lomuscio G; Bestagno M
    Tumori; 1990 Oct; 76(5):484-7. PubMed ID: 2256196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of carcinoid tumors with [131I] meta-iodo-benzyl-guanidine.
    Adolph J; Kimmig B; Eisenhut M; Georgi P
    Recent Results Cancer Res; 1988; 110():281-5. PubMed ID: 3406506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.